The protective effect of SLC7A5-deletion in T cells has been previously described in inflammatory mouse models of psoriasis (Cibrian et al, 2020), allergic diseases (Hayashi et al, 2020), and rheumatoid arthritis (Ogbechi et al, 2023). Here, SLC7A5 is linked to psoriasis.